BDBM72344 3-[benzyl(ethyl)sulfamoyl]-N-(cyclohexylmethyl)-4-methoxy-benzamide::3-[benzyl(ethyl)sulfamoyl]-N-(cyclohexylmethyl)-4-methoxybenzamide::MLS000393061::N-(cyclohexylmethyl)-3-[ethyl-(phenylmethyl)sulfamoyl]-4-methoxy-benzamide::N-(cyclohexylmethyl)-3-[ethyl-(phenylmethyl)sulfamoyl]-4-methoxybenzamide::SMR000247374::cid_2595023

SMILES O=C1c2cc(F)c(Br)cc2N2CN1c1ccc(=O)[nH]c1CCNCc1c2ccc(F)c1F

InChI Key InChIKey=NOFQDFHKAYPLFT-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 72344   

TargetSodium channel protein type 10 subunit alpha(Human)
Glaxosmithkline Intellectual Property Development

US Patent
LigandChemical structure of BindingDB Monomer ID 72344BDBM72344(3-Bromo-2,8,9-trifluoro-10,11,12,13-tetrahydro-19H...)
Affinity DataIC50: 6.31nMAssay Description:Keywords: Heat Shock Factor-1 (HSF-1), Stress Response, MG132, NIH3T3, Luminescence Assay Overview: Modified NIH3T3, transformed to express firefly...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/16/2026
Entry Details
US Patent